Yoshikazu Tamori
Overview
Explore the profile of Yoshikazu Tamori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
2406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamada T, Asahara S, Kimura-Koyanagi M, Tamori Y, Muramae N, Mori K, et al.
Diabetol Int
. 2023 Jul;
14(3):294-297.
PMID: 37397904
Supplementary Information: The online version contains supplementary material available at 10.1007/s13340-023-00621-5.
2.
Yamada T, Kimura-Koyanagi M, Sakaguchi K, Ogawa W, Tamori Y
Sci Rep
. 2023 Feb;
13(1):2346.
PMID: 36759688
Diabetes, hypertension, and dyslipidemia are obesity-related comorbidities that contribute to the development of cardiovascular disease, one of the leading causes of death. In addition to obesity, the underweight condition is...
3.
Bando H, Miura H, Kitahama S, Nakajima S, Takahashi T, Mihara T, et al.
Obes Surg
. 2023 Jan;
33(3):851-859.
PMID: 36626105
Background: Bariatric surgery is an effective treatment for severe obesity and its associated medical problems. Preoperative factors that predict postoperative weight loss remain to be fully characterized, however. Methods: Anthropometric...
4.
Slayton M, Balakrishnan B, Gupta A, Jobe S, Puri I, Neely S, et al.
Am J Physiol Endocrinol Metab
. 2022 Feb;
322(4):E331-E343.
PMID: 35157807
Fsp27 was previously identified as a lipid droplet-associated protein in adipocytes. Various studies have shown that it plays a role in the regulation of lipid homeostasis in adipose tissue and...
5.
Miura H, Sakaguchi K, Ogawa W, Tamori Y
Geriatr Gerontol Int
. 2021 Jun;
21(8):689-696.
PMID: 34164909
Aim: The prevalence of sarcopenia and the health status of affected individuals, particularly among the young elderly, are unclear in Japan. We determined the prevalence of possible sarcopenia, a concept...
6.
Otowa-Suematsu N, Sakaguchi K, Kaneko A, Ito J, Morita Y, Miura H, et al.
J Diabetes Investig
. 2021 Jun;
12(12):2197-2202.
PMID: 34081831
Aims: Whereas homeostasis model assessment of insulin resistance (HOMA-IR), an easily measured but limited index of insulin resistance, has been shown to correlate with impairment of cardiac function in individuals...
7.
Yamada T, Sakaguchi K, Okada Y, Miura H, Otowa-Suematsu N, So A, et al.
Diabetol Int
. 2021 Mar;
12(2):197-206.
PMID: 33786274
Sodium-glucose cotransporter 2 (SGLT2) inhibitors often increase the hematocrit. It remains unclear whether this increase would be observed in all patients administered SGLT2 inhibitors, however. We therefore used the data...
8.
Nabatame Y, Hosooka T, Aoki C, Hosokawa Y, Imamori M, Tamori Y, et al.
J Diabetes Investig
. 2021 Jan;
12(7):1144-1151.
PMID: 33480176
Aims/introduction: Brown adipose tissue (BAT) utilizes large amounts of fuel for thermogenesis, but the mechanism by which fuel substrates are switched in response to changes in energy status is poorly...
9.
Asahara S, Miura H, Ogawa W, Tamori Y
PLoS One
. 2020 Nov;
15(11):e0242105.
PMID: 33237961
The development of obesity is influenced by genetic and environmental factors and is associated with a variety of health problems. To gain insight into environmental factors that contribute to obesity,...
10.
Ito J, Nogami M, Morita Y, Sakaguchi K, Komada H, Hirota Y, et al.
Diabetes Obes Metab
. 2020 Nov;
23(3):692-699.
PMID: 33236523
Aim: To investigate the relationships between various clinical variables and the metformin-induced accumulation of fluorodeoxyglucose (FDG) in the intestine, with distinction between the intestinal wall and lumen, in individuals with...